Apogee Therapeutics, Inc.
APGE
$82.93
-$1.67-1.97%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.81% | -6.71% | 1.63% | -19.44% | 17.67% |
| Total Depreciation and Amortization | 0.49% | 0.00% | 1.75% | 92.75% | 172.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.79% | -0.45% | 6.59% | 9.38% | 78.38% |
| Change in Net Operating Assets | 131.86% | -480.05% | 87.76% | -131.84% | 50.49% |
| Cash from Operations | 11.36% | -15.55% | 12.53% | -27.96% | 28.41% |
| Capital Expenditure | -- | -- | 100.00% | 82.21% | -431,800.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 87.75% | -1,708.05% | -77.25% | 356.06% | -62.69% |
| Cash from Investing | 87.75% | -1,708.39% | -77.03% | 501.79% | -72.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.66% | 1,799.64% | 1,572.71% | 89.71% | -98.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.66% | 1,799.64% | 1,572.71% | 89.71% | -98.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,254.97% | 242.62% | -195.92% | 149.54% | -251.56% |